About Sime Dx
Sime Dx is a company based in London (United Kingdom) founded in 2010. Sime Dx has raised $970.9 thousand across 5 funding rounds from investors including Oxford Technology and European Union. The company has 8 employees as of March 31, 2022. Sime Dx offers products and services including Point-of-care Device and AI Diagnostic Platform. Sime Dx operates in a competitive market with competitors including Viz.ai, PathAI, Deepcell, Aignostics and Deciphex, among others.
- Headquarter London, United Kingdom
- Employees 8 as on 31 Mar, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Sime Diagnostics Limited
- Date of Incorporation 07 Feb, 2014
- Jurisdiction LONDON, ENGLAND
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$970.9 K (USD)
in 5 rounds
-
Latest Funding Round
$626 K (USD), Seed
May 12, 2020
-
Investors
Oxford Technology
& 1 more
-
Employee Count
8
as on Mar 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Sime Dx
Sime Dx offers a comprehensive portfolio of products and services, including Point-of-care Device and AI Diagnostic Platform.
Rapidly predicts lung diseases in ICU using AI technology.
Offers algorithms for early respiratory disease prediction in neonates.
People of Sime Dx
Unlock access to complete
Finance and Accounting
2 people
Head Team
1 people
Leadership Team
1 people
Software Development Team
1 people
Unlock access to complete
Funding Insights of Sime Dx
Sime Dx has successfully raised a total of $970.9K across 5 strategic funding rounds. The most recent funding activity was a Seed round of $626 thousand completed in May 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sime Dx
Sime Dx has secured backing from 2 investors, including venture fund and institutional investors. Prominent investors backing the company include Oxford Technology and European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage micro-VC investments are focused on UK companies.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Sime Dx
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sime Dx
Investment portfolio details for Sime Dx
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sime Dx
Detailed financials for Sime Dx
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sime Dx Comparisons
Peer comparison for Sime Dx
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sime Dx
Sime Dx operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Viz.ai, PathAI, Deepcell, Aignostics and Deciphex, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
AI and cloud-powered software for stroke care coordination is developed.
|
|
| Locked | Locked | Locked |
Provider of AI-based solutions for clinical diagnosis of cancer and other diseases
|
|
| Locked | Locked | Locked |
AI-powered single cell classification and isolation technology for clinical research
|
|
| Locked | Locked | Locked |
AI-based pathology diagnostic software is provided for medical analysis.
|
|
| Locked | Locked | Locked |
Digital pathology software is developed for clinical and veterinary productivity.
|
|
| Locked | Locked | Locked |
Provides image analysis and data mining solutions for quantitative digital pathology in the healthcare industry
|
Detailed competitors of Sime Dx
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sime Dx
Complete news archive for Sime Dx
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sime Dx
Sime Dx was founded in 2010 and raised its 1st funding round 4 years after it was founded.
Sime Dx is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.
Sime Dx is a funded company, having raised a total of $970.9K across 5 funding rounds to date.
As of Mar 31, 2022, the latest employee count at Sime Dx is 8.
Founded in 2010, Sime Dx is headquartered in London, United Kingdom. Digital diagnostics for point-of-care applications are created and distributed by the company within the healthcare sector. Services focus on enabling rapid testing and analysis directly at patient sites, supporting clinical decision-making. Operations emphasize technology integration for diagnostics, with the domain simedx.com serving as the primary online presence.
Sime Dx's top competitors include Aignostics, Deciphex and Pictor Labs.
Sime Dx offers Point-of-care Device and AI Diagnostic Platform.
Sime Dx has 2 investors. Key investors include Oxford Technology, and European Union.